AJ Vaccines A/S: Financial statements 2021
CVR: 37911143
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
AJ Vaccines A/S (CVR 37911143) has filed annual accounts for 2021. In 2021, the company reported revenue of DKK 351,862,000 and a net result of DKK -486,388,000 compared with DKK -450,212,000 the year before. The profit margin was -138.2%. Equity in the 2021 report amounted to DKK 815,875,000. The solvency ratio was 55.4%. The company had 558 employees in the financial year.
- Revenue
- DKK 351,862,000
- Gross Profit
- DKK -303,976,000
- Profit/Loss
- DKK -486,388,000
- Equity
- DKK 815,875,000
- Total Assets
- DKK 1,472,466,000
- Employees
- 558
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | 351.9M | -304M | -486.4M | 815.9M | 558 |
| 2020 | 351.6M | -313.9M | -450.2M | 1.1B | 702 |
| 2019 | 323.5M | -224.5M | -288.6M | 1.2B | 719 |
| 2018 | 362.2M | -150.7M | -244.5M | 903.2M | 0 |
Official annual report
Find more companies like AJ Vaccines A/S
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2021
AJ Vaccines A/S has published its annual report for 2020. Revenue came to DKK 351,618,000, and the net result was DKK -450,212,000.
As of March 24, 2021, Mohammed Ali A Alesayi has joined the board of directors of AJ Vaccines A/S.
As of March 24, 2021, Abdulaziz Hamad Aljomaih has joined the board of directors of AJ Vaccines A/S.
As of March 24, 2021, Shan-E-Abbas Ashary has left the board of directors of AJ Vaccines A/S.
As of March 24, 2021, Abdul Wahab Mohammed A Alesayi has left the board of directors of AJ Vaccines A/S.
As of January 28, 2021, Jérome Christian Roger Cabannes has stepped down as director of AJ Vaccines A/S.
About AJ Vaccines A/S
AJ Vaccines A/S is a Danish company of the type Aktieselskab based in København S, founded in 2016. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named Aktieselskabet af august 2016. The management consists of Ole Vahlgren. The board consists of Abdulaziz Abdulhamid Abdulrhman Albassam (chair), Mohammed Ali A Alesayi, Mustafa Nasir Farooki and Saddam Abdulqawi Hussein Alhumaikani. The company is owned by AJ Vaccines Holding ApS. The company has 499 employees (2026). In 2025, the company reported revenue of DKK 389,681,000 and a net result of DKK -483,351,000 compared with DKK -807,117,000 the year before. Equity in the 2025 report amounted to DKK 288,465,000.
